Australia’s CSL reaffirms commitment to making AstraZeneca COVID vaccine

(Reuters) – Australian biotech CSL said on Thursday it was committed to its agreement for the production of about 50 million doses of AstraZeneca’s COVID-19 vaccine into 2022.

The announcement came after a media report said the British drugmaker’s vaccine,…

Click here to view the original article.